Skip to main content

Corporate insider profile

John M. Evans Insider Trades

Latest reported as CEO of Beam Therapeutics Inc. (BEAM).

Purchase filings
0
Reported companies
1
Net open-market value
-$2,933,780.00
Latest transaction
Oct 16, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 16, 2026Beam Therapeutics Inc. (BEAM)CEOSale50,000$23.77$1,188,745
Jun 30, 2026Beam Therapeutics Inc. (BEAM)CEOSale50,000$34.90$1,745,035